Litcius/Paper detail

Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial

Bernadette Brennan, Laura Kirton, Perrine Marec‐Bérard, Nathalie Gaspar, Valérie Laurence, Javier Martín‐Broto, Ana Méndez‐Echevarría, Hans Gelderblom, Cormac Owens, Nicola Fenwick, Sandra J. Strauss, V. V. Moroz, Jeremy Whelan, Keith Wheatley

2022The Lancet126 citationsDOIOpen Access PDF

Topics & Concepts

IfosfamideEtoposideMedicineVincristineRegimenMelphalanCyclophosphamideSarcomaOncologyChemotherapySurgeryInternal medicineInduction chemotherapyDoxorubicinPathologySarcoma Diagnosis and TreatmentCardiac tumors and thrombiManagement of metastatic bone disease
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial | Litcius